Management ChangeSep 29, 2026, 04:31 PM
NanoViricides Extends Employment for President and CFO
AI Summary
NanoViricides, Inc. announced the extension of employment agreements for key executives. Dr. Anil R. Diwan's term as President has been extended to June 30, 2027, with a base salary of $400,000 and a grant of 10,204 Series A Preferred Stock shares. Meeta Vyas's term as CFO has also been extended for one year through June 30, 2027, with continued monthly compensation and enhanced health insurance reimbursement.
Key Highlights
- Dr. Anil R. Diwan's employment agreement as President extended to June 30, 2027, with an annual base salary of $400,000.
- Dr. Diwan granted 10,204 shares of Series A Preferred Stock, vesting quarterly from September 30, 2026, to June 30, 2027.
- Meeta Vyas's employment agreement as CFO extended for one year through June 30, 2027, with monthly compensation of $10,800.
- CFO to be reimbursed up to 50% of Health Insurance costs, not exceeding $2,500 per month.
Price Impact
More from NNVC